My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 202

    1.

    Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.

    Raskin P, Allen E, Hollander P, Lewin A, Gabbay RA, Hu P, Bode B, Garber A; INITIATE Study Group.

    Diabetes Care. 2005 Feb;28(2):260-5.PMID: 15677776 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

    Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.

    Clin Ther. 2007 Nov;29(11):2374-84.PMID: 18158078 [PubMed - indexed for MEDLINE]Related articles

    3.

    Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).

    Raskin P, Matfin G, Schwartz SL, Chaykin L, Chu PL, Braceras R, Wynne A.

    Diabetes Obes Metab. 2009 Jan;11(1):27-32. Epub 2007 Oct 17.PMID: 17941873 [PubMed - indexed for MEDLINE]Related articles

    4.

    Starting insulin therapy in type 2 diabetes: twice-daily biphasic insulin Aspart 30 plus metformin versus once-daily insulin glargine plus glimepiride.

    Kann PH, Wascher T, Zackova V, Moeller J, Medding J, Szocs A, Mokan M, Mrevlje F, Regulski M.

    Exp Clin Endocrinol Diabetes. 2006 Oct;114(9):527-32.PMID: 17115351 [PubMed - indexed for MEDLINE]Related articles

    5.

    Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes.

    Janka HU, Plewe G, Riddle MC, Kliebe-Frisch C, Schweitzer MA, Yki-Järvinen H.

    Diabetes Care. 2005 Feb;28(2):254-9.PMID: 15677775 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in randomized elderly patients with type 2 diabetes mellitus.

    Janka HU, Plewe G, Busch K.

    J Am Geriatr Soc. 2007 Feb;55(2):182-8.PMID: 17302653 [PubMed - indexed for MEDLINE]Related articles

    7.

    Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).

    Garber AJ, Wahlen J, Wahl T, Bressler P, Braceras R, Allen E, Jain R.

    Diabetes Obes Metab. 2006 Jan;8(1):58-66.PMID: 16367883 [PubMed - indexed for MEDLINE]Related articles

    8.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    9.

    Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.

    Barnett AH, Burger J, Johns D, Brodows R, Kendall DM, Roberts A, Trautmann ME.

    Clin Ther. 2007 Nov;29(11):2333-48.PMID: 18158075 [PubMed - indexed for MEDLINE]Related articles

    10.

    Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes.

    Kvapil M, Swatko A, Hilberg C, Shestakova M.

    Diabetes Obes Metab. 2006 Jan;8(1):39-48.PMID: 16367881 [PubMed - indexed for MEDLINE]Related articles

    11.

    Basal insulin or premix analogue therapy in type 2 diabetes patients.

    Raskin PR, Hollander PA, Lewin A, Gabbay RA, Bode B, Garber AJ; on behalf of the INITIATE Study Group.

    Eur J Intern Med. 2007 Jan;18(1):56-62.PMID: 17223044 [PubMed - in process]Related articles

    12.

    Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy.

    Malone JK, Kerr LF, Campaigne BN, Sachson RA, Holcombe JH; Lispro Mixture-Glargine Study Group.

    Clin Ther. 2004 Dec;26(12):2034-44. Erratum in: Clin Ther. 2005 Jul;27(7):1112. PMID: 15823767 [PubMed - indexed for MEDLINE]Related articles

    13.

    Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.

    Rosenstock J, Sugimoto D, Strange P, Stewart JA, Soltes-Rak E, Dailey G.

    Diabetes Care. 2006 Mar;29(3):554-9.PMID: 16505505 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: an 18-week, randomized, open-label study.

    Raz I, Stranks S, Filipczak R, Joshi P, Lertoft B, Rastam J, Chow CC, Shaban J.

    Clin Ther. 2005 Sep;27(9):1432-43.PMID: 16291416 [PubMed - indexed for MEDLINE]Related articles

    15.

    Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs.

    Yang W, Ji Q, Zhu D, Yang J, Chen L, Liu Z, Yu D, Yan L.

    Diabetes Care. 2008 May;31(5):852-6. Epub 2008 Feb 11.PMID: 18268073 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.

    Hollander P, Cooper J, Bregnhøj J, Pedersen CB.

    Clin Ther. 2008 Nov;30(11):1976-87.PMID: 19108786 [PubMed - indexed for MEDLINE]Related articles

    17.

    The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.

    Riddle MC, Rosenstock J, Gerich J; Insulin Glargine 4002 Study Investigators.

    Diabetes Care. 2003 Nov;26(11):3080-6.PMID: 14578243 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial.

    Davies M, Lavalle-González F, Storms F, Gomis R; AT.LANTUS Study Group.

    Diabetes Obes Metab. 2008 May;10(5):387-99. Epub 2008 Mar 18.PMID: 18355327 [PubMed - indexed for MEDLINE]Related articles

    19.

    Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

    Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs.

    Lankisch MR, Ferlinz KC, Leahy JL, Scherbaum WA; Orals Plus Apidra and LANTUS (OPAL) study group.

    Diabetes Obes Metab. 2008 Dec;10(12):1178-85.PMID: 19040645 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity